Skip to main content

Table 8 Medicinal cannabis extract use preferences among various pain syndromes and “Yes” responses on ID Migraine™ questionnaire

From: Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort

Cannabis extracts (drops, capsules)
  Total Hybrid Indica Sativa 3:1 CBD:THC 1:1 CBD:THC
Headache as primary symptom (505) 195 (38.6%) 36 (18.5%) 51 (26.2%) 15 (7.7%) 53 (27.2%) 40 (20.5%)
Headache as primary illness (75) 26 (34.7%) 7 (26.9%) 5 (19.2%) 1 (3.9%) 9 (34.6%) 4 (15.4%)
Chronic pain as primary illness (598) 248 (41.5%) 44 (17.7%) 56 (22.6%) 18 (7.3%) 60 (24.2%) 66 (26.6%)
Arthritis as primary illness (188) 80 (42.6%) 14 (17.5%) 11 (13.8%) 5 (6.3%) 26 (32.5%) 24 (30%)
3 Yes (343)a 143 (41.7%) 25 (17.5%) 41 (28.7%) 6 (4.2%) 39 (27.3%) 32 (22.4%)
2 Yes (102)b 33 (32.4%) 6 (18.2%) 7 (21.2%) 5 (15.2%) 9 (27.3%) 6 (18.2%)
3 + 2 Yes (445) 176 (39.6%) 31 (17.6%) 48 (27.3%) 11 (6.3%) 48 (27.3%) 38 (21.6%)
  1. a3 “Yes” responses = 97% probability of migraine
  2. b2 “Yes” responses = 93% probability of migraine